JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB281915

Anti-GABA A Receptor beta 2/GABRB2 + GABA A Receptor gamma 2/GABRG2 + GABA A Receptor alpha 1 antibody [1F4]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal GABA A Receptor alpha 1 antibody. Suitable for ICC and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Full Length Protein corresponding to Human GABRA1.

View Alternative Names

Gamma-aminobutyric acid receptor subunit alpha-1, GABA(A) receptor subunit alpha-1, GABAAR subunit alpha-1, GABRA1

1 Images
Immunocytochemistry - Anti-GABA A Receptor beta 2/GABRB2 + GABA A Receptor gamma 2/GABRG2 + GABA A Receptor alpha 1 antibody [1F4] (AB281915)
  • ICC

Supplier Data

Immunocytochemistry - Anti-GABA A Receptor beta 2/GABRB2 + GABA A Receptor gamma 2/GABRG2 + GABA A Receptor alpha 1 antibody [1F4] (AB281915)

U251 cells stained for GABA A Receptor gamma 2/GABRG2 + GABA A Receptor alpha 1 + GABA Receptor Beta 2 (green) using ab281915 at 10 μg/ml for 1 hour, followed by Alexa Fluor® 488 secondary antibody at 2 μg/ml in ICC. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom ab281915, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor® 488 secondary antibody.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

1F4

Isotype

IgG

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

ICC

applications

Immunogen

Full Length Protein corresponding to Human GABRA1. The exact immunogen used to generate this antibody is proprietary information.

P14867

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "10 µg/mL", "ICC-species-notes": "<p></p>" } } }

Product details

ab281915 is the rabbit chimera vesion of ab281914.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.02% Proclin 300 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed : 23909897, PubMed : 25489750, PubMed : 29950725, PubMed : 30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed : 29950725, PubMed : 30602789). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed : 23909897, PubMed : 29950725, PubMed : 30602789). Alpha-1/GABRA1-containing GABAARs are largely synaptic (By similarity). Chloride influx into the postsynaptic neuron following GABAAR opening decreases the neuron ability to generate a new action potential, thereby reducing nerve transmission (By similarity). GABAARs containing alpha-1 and beta-2 or -3 subunits exhibit synaptogenic activity; the gamma-2 subunit being necessary but not sufficient to induce rapid synaptic contacts formation (PubMed : 23909897, PubMed : 25489750). GABAARs function also as histamine receptor where histamine binds at the interface of two neighboring beta subunits and potentiates GABA response (By similarity). GABAARs containing alpha, beta and epsilon subunits also permit spontaneous chloride channel activity while preserving the structural information required for GABA-gated openings (By similarity). Alpha-1-mediated plasticity in the orbitofrontal cortex regulates context-dependent action selection (By similarity). Together with rho subunits, may also control neuronal and glial GABAergic transmission in the cerebellum (By similarity).
See full target information GABRA1

Additional targets

GABRG2,GABRB2

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Nature 559:67-72 PubMed29950725

2018

Structure of a human synaptic GABA receptor.

Applications

Unspecified application

Species

Unspecified reactive species

Shaotong Zhu,Colleen M Noviello,Jinfeng Teng,Richard M Walsh,Jeong Joo Kim,Ryan E Hibbs
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com